Carle is home to some of the most advanced neuroscience services and technology available. Our team of specialists is uniquely trained to treat diseases and injuries of the brain, spine, spinal cord and nervous system. Our comprehensive range of neuroscience diagnostic and surgical services help thousands of area patients live longer, manage their conditions and discover an improved quality of life.
Brain and skull base tumors can be difficult for patients as well as their loved ones. Carle is here to provide the highest level of care possible.
Carle Foundation Hospital is accredited by the NAEC as a level 3 epilepsy center.
Our team has experience treating all types of conditions of the brain, spine, and nervous system and works together to determine the best treatment for your individual needs.
Carle neuro-ophthalmologists are specially trained in both neurology and ophthalmology and use leading edge techniques to diagnose vision issues related to conditions such as brain injury, stroke, tumors, multiple sclerosis, migraines and more.
Clinical neuropsychology examines the relationship between brain anatomy and cognitive abilities such as attention/concentration, memory, problem solving and language, and how these abilities may be affected by injury or disease.
Carle Neuroscience Institute is home to a dedicated team of board-certified neurosurgeons, specializing in surgical care for patients with complex brain and spine conditions.
Our multidisciplinary approach offers comprehensive care for a range of spinal conditions without surgical intervention and can provide pain management therapies.
Carle’s Sleep Medicine specialists can assess, diagnose and treat a full range of sleep disorders for both adults and children.
The spine specialists at Carle Neuroscience Institute are focused on identifying the source of your back or neck pain so they can develop an individualized treatment plan to get you back to regular activity.
As the only certified Comprehensive Stroke Center in the region in a Level I Trauma Center, Carle Foundation Hospital has neurosurgeons and neurointerventional specialists available 24/7 to ensure faster stroke treatment and better outcomes for patients experiencing a stroke.
Have a patient referral? Refer a patient now.
Neuroscience research at Carle represents the intersection of technology, medicine, science, and care. By providing our patients with the opportunity to participate in translational and clinical studies we hope to engage them in not only their own care but also the future of medicine. Our researchers and providers strive to advance diagnostic capabilities, understand causes and effects, and improve patient quality of life. Our research department supports clinicians and faculty alike in their efforts to provide excellent care and perform extraordinary science.
By participating in research studies, Carle Neuroscience Institute seeks to create a better understanding of the structure and function of neurological systems allowing us to advance clinical care possible and ultimately improve the overall promotion of human health and quality of life.
Carle Neuroscience Institute Research is known for demonstrating improved clinical outcomes for patients through research efforts that focus on the development of predictive analysis, novel diagnostics, and comparative efficacy.
The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.
This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout North America. Information on FMT methodology employed (e.g., screening of donor and recipient, preparation, FMT delivery) will be collected from each site. The indication for FMT as well as baseline information on recipient will also be collected. Following FMT, patients will be followed at regular intervals up to 10 years post FMT. This will include follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year, and 2 years after FMT as well as direct communication with patients at least annually up to 10 years after FMT. Follow-up information collected will be designed to assess potential short-term and long-term safety and effectiveness.
The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.